Agilon Health Stock EBITDA
| AGL Stock | USD 1.78 0.11 6.59% |
agilon health fundamentals help investors to digest information that contributes to Agilon Health's financial success or failures. It also enables traders to predict the movement of Agilon Stock. The fundamental analysis module provides a way to measure Agilon Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Agilon Health stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | -167.6 M | -176 M |
Agilon | EBITDA |
agilon health Company EBITDA Analysis
Agilon Health's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Agilon Health EBITDA | (167.64 M) |
Most of Agilon Health's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, agilon health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Agilon EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for Agilon Health is extremely important. It helps to project a fair market value of Agilon Stock properly, considering its historical fundamentals such as EBITDA. Since Agilon Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Agilon Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Agilon Health's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Agilon Ebitda
According to the company disclosure, agilon health reported earnings before interest,tax, depreciation and amortization of (167.64 Million). This is 119.11% lower than that of the Health Care Providers & Services sector and significantly lower than that of the Health Care industry. The ebitda for all United States stocks is 104.3% higher than that of the company.
Agilon EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Agilon Health's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Agilon Health could also be used in its relative valuation, which is a method of valuing Agilon Health by comparing valuation metrics of similar companies.Agilon Health is currently under evaluation in ebitda category among its peers.
Agilon Health Institutional Holders
Institutional Holdings refers to the ownership stake in Agilon Health that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Agilon Health's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Agilon Health's value.| Shares | Bank Of America Corp | 2024-06-30 | 4.8 M | Charles Schwab Investment Management Inc | 2024-09-30 | 3 M | Millennium Management Llc | 2024-06-30 | 2.8 M | Northern Trust Corp | 2024-09-30 | 2.6 M | Iron Triangle Partners Lp | 2024-06-30 | 2.5 M | Deutsche Bank Ag | 2024-06-30 | 1.8 M | Citadel Advisors Llc | 2024-06-30 | 1.5 M | Aqr Capital Management Llc | 2024-06-30 | 1.4 M | Goldman Sachs Group Inc | 2024-06-30 | 1.3 M | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 112.8 M | Clayton Dubilier & Rice Llc | 2024-09-30 | 100 M |
Agilon Fundamentals
| Return On Equity | -0.43 | ||||
| Return On Asset | -0.0984 | ||||
| Profit Margin | (0.07) % | ||||
| Operating Margin | (0.09) % | ||||
| Current Valuation | 384.37 M | ||||
| Shares Outstanding | 412.02 M | ||||
| Shares Owned By Insiders | 1.78 % | ||||
| Shares Owned By Institutions | 98.22 % | ||||
| Number Of Shares Shorted | 36.22 M | ||||
| Price To Earning | 23.14 X | ||||
| Price To Book | 1.28 X | ||||
| Price To Sales | 0.13 X | ||||
| Revenue | 4.32 B | ||||
| Gross Profit | 112.29 M | ||||
| EBITDA | (167.64 M) | ||||
| Net Income | (262.8 M) | ||||
| Cash And Equivalents | 497.07 M | ||||
| Cash Per Share | 2.32 X | ||||
| Total Debt | 52.31 M | ||||
| Debt To Equity | 0.05 % | ||||
| Current Ratio | 2.65 X | ||||
| Book Value Per Share | 1.40 X | ||||
| Cash Flow From Operations | (156.2 M) | ||||
| Short Ratio | 8.10 X | ||||
| Earnings Per Share | (0.76) X | ||||
| Price To Earnings To Growth | 0.19 X | ||||
| Target Price | 3.63 | ||||
| Number Of Employees | 1.12 K | ||||
| Beta | 0.6 | ||||
| Market Capitalization | 733.39 M | ||||
| Total Asset | 1.74 B | ||||
| Retained Earnings | (1.33 B) | ||||
| Working Capital | 502.92 M | ||||
| Current Asset | 1.54 B | ||||
| Current Liabilities | 2.49 B | ||||
| Net Asset | 1.74 B |
About Agilon Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze agilon health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Agilon Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of agilon health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Agilon Health Piotroski F Score and Agilon Health Altman Z Score analysis. For more information on how to buy Agilon Stock please use our How to buy in Agilon Stock guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agilon Health. If investors know Agilon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agilon Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 11.951 | Earnings Share (0.76) | Revenue Per Share 13.717 | Quarterly Revenue Growth 0.276 | Return On Assets (0.1) |
The market value of agilon health is measured differently than its book value, which is the value of Agilon that is recorded on the company's balance sheet. Investors also form their own opinion of Agilon Health's value that differs from its market value or its book value, called intrinsic value, which is Agilon Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agilon Health's market value can be influenced by many factors that don't directly affect Agilon Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agilon Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Agilon Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agilon Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.